TET2 and hepatocellular carcinoma: Altogether, TET2 (Y1902F) demonstrated more apparent inhibitive effect on proliferation than TET2 (WT) in SMMC-7721/FGFR3∆7–9 and HepG2/FGFR3∆7–9 cells HCC cells.